Citadel Advisors
ONCY

Citadel Advisors’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Citadel Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,000
Closed -$6K – 9689
2015
Q3 		$6K Buy
+12,000
New +$6.87K ﹤0.01% 8622
2015
Q1 		– Sell
-1,900
Closed -$1K – 9152
2014
Q4 		$1K Buy
1,900
+100
+6% +$60 ﹤0.01% 8439
2014
Q3 		$1K Sell
1,800
-7,600
-81% -$9.62K ﹤0.01% 8057
2014
Q2 		$12K Sell
9,400
-4,900
-34% -$7.02K ﹤0.01% 7540
2014
Q1 		$26K Sell
14,300
-1,600
-10% -$2.7K ﹤0.01% 7175
2013
Q4 		$25K Buy
+15,900
New +$35.8K ﹤0.01% 6359

Other funds holding ONCY

NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
KWMG
King Wealth Management Group Naples, Florida $800M AUM 22.41% 1-Year Est. Return
CS
Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Citadel Advisors's ONCY Position: Q4 2015 in Review

Citadel Advisors sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 38,262 shares — an estimated $18K sold.

Citadel Advisors first reported a position in ONCY in Q2 2014 and held it in 4 quarters. The position peaked at $20K in Q4 2014. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Citadel Advisors reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Citadel Advisors sold 38,262 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $18K.
  • Citadel Advisors first reported a position in ONCOLYTICS BIOTECH INC in Q2 2014 and held it in 4 quarters.
  • Citadel Advisors's ONCOLYTICS BIOTECH INC position peaked at $20K in Q4 2014.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.